ESR1 and breast cancer: Furthermore, the activation of the p-p38/CK2 complex was reported to cause a downregulation of ER-α transcription, expression and thus activity (De Amicis et al. 2013), while CK2 inhibition was recently correlated with an increased ERα expression in breast cancer patients (Williams et al. 2015).